Egetis Therapeutics AB (publ)
STO:EGTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Egetis Therapeutics AB (publ)
STO:EGTX
|
SE |
|
A
|
AniPlus Inc
KOSDAQ:310200
|
KR |
|
Great-West Lifeco Inc
TSX:GWO
|
CA |
|
C
|
Clarus Corp
F:BDO
|
US |
|
Wuxi Hyatech Co Ltd
SSE:688510
|
CN |
|
Milestone Pharmaceuticals Inc
NASDAQ:MIST
|
CA |
|
Ignite Nutra Inc
OTC:GPRC
|
CN |
|
K
|
Khon Kaen Sugar Industry PCL
SET:KSL
|
TH |
|
L
|
Lexeo Therapeutics Inc
NASDAQ:LXEO
|
US |
Intrinsic Value
The intrinsic value of one
EGTX
stock under the Base Case scenario is
hidden
SEK.
Compared to the current market price of 5.77 SEK,
Egetis Therapeutics AB (publ)
is
hidden
.
EGTX looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether EGTX usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Egetis Therapeutics AB (publ).
The intrinsic value of one
EGTX
stock under the Base Case scenario is
hidden
SEK.
Compared to the current market price of 5.77 SEK,
Egetis Therapeutics AB (publ)
is
hidden
.